MedTrace Logo

Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms

NCT05259384 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-02-28

No results posted yet for this study

Summary

Pancreatic cystic neoplasm (PCN) is a type of neoplastic lesion formed by the proliferation of pancreatic duct or acinar epithelial cells and retention of pancreatic secretions. The tumor can be located in the head and neck of the pancreas or the body and tail of the pancreas. Conventionally, open pancreaticoduodenectomy or open distal pancreatectomy was performed for patients with PCN locates either at the head or tail. In the ear of minimally invasive pancreatic surgery, when compared with open surgery, laparoscopic technology or Da Vinci robotic technology can avoid some open procedures limitations.

Here we design this prospective randomized clinical trial to compare robotic surgery to laparoscopic surgery for the treatment of PCN and verify the safety and feasibility of both two minimally invasive procedures.

Conditions

  • Pancreatic Neoplasm

Interventions

PROCEDURE

Robotic pancreaticoduodenectomy

The Intervention of MIPD-ROB group

PROCEDURE

Laparoscopic pancreaticoduodenectomy

The Intervention of MIPD-LAP group

PROCEDURE

Robotic Distal Pancreatectomy

The Intervention of MIDP-ROB group

PROCEDURE

Laparoscopic Distal Pancreatectomy

The Intervention of MIDP-LAP group

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • MENGHUA Dai, M.D. · Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-17
Primary Completion
2024-04-30
Completion
2024-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05259384 on ClinicalTrials.gov